U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154524) titled 'Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)' on Aug. 27.
Brief Summary: This study is designed as an explorative study aiming at exploring safety and efficacy of immunoadsorption (IA) in patients with Chronic Inflammatory Demyelinating Poly-neuropathy (CIDP) compared to intravenous immunoglobulins (IVIg) and methyl-prednisolone (MP). For this purpose, approximately 140 patients with CIDP will be included within the framework of the German multicenter network "Kompetenznetz Peripherer Nerv" (KKPNS).
The study will be purely observational. IA will be performed as an escalation therapy, i...